Kerala HC to Centre: Consider Compulsory Licensing of Drug Ribociclib - (22 Jun 2022)
INTELLECTUAL PROPERTY RIGHTS
Kerala High Court has directed the Department for Promotion of Industry and Internal Trade to consider compulsory licensing of Ribociclib, a breast cancer drug, considering the alarming number of women who succumb to the disease merely because they could not afford treatment.
Tags : KERALA HIGH COURT COMPULSORY LICENSING BREAST CANCER
Share :
|